Eventide Asset Management LLC Makes New $554,000 Investment in Doximity, Inc. $DOCS

Key Points

• Eventide Asset Management LLC has acquired 9,534 shares of Doximity, Inc. valued at approximately $554,000, indicating increasing interest in the company's stock.
• Doximity's recent earnings report showed $0.36 EPS, surpassing analysts' expectations and demonstrating a 15.2% year-over-year revenue growth.
• Analysts have set a consensus price target of $66.21 for Doximity, with a mix of ratings including two Strong Buy and ten Buy ratings.

Eventide Asset Management LLC acquired a new position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 9,534 shares of the company's stock, valued at approximately $554,000.

A number of other institutional investors have also recently bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in Doximity by 8.8% in the 1st quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company's stock worth $707,646,000 after purchasing an additional 990,923 shares during the period. Invesco Ltd. lifted its holdings in shares of Doximity by 54.8% in the first quarter. Invesco Ltd. now owns 1,969,326 shares of the company's stock valued at $114,280,000 after purchasing an additional 696,923 shares in the last quarter. Fuller & Thaler Asset Management Inc. boosted its position in shares of Doximity by 9.5% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,730,282 shares of the company's stock worth $100,408,000 after buying an additional 150,574 shares during the period. Bank of New York Mellon Corp grew its holdings in shares of Doximity by 8.2% during the first quarter. Bank of New York Mellon Corp now owns 1,137,912 shares of the company's stock worth $66,033,000 after buying an additional 86,135 shares in the last quarter. Finally, SG Americas Securities LLC acquired a new stake in Doximity in the 1st quarter valued at approximately $65,702,000. Institutional investors own 87.19% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have weighed in on DOCS. Needham & Company LLC upped their price target on Doximity from $67.00 to $75.00 and gave the stock a "buy" rating in a research report on Friday, August 8th. Mizuho cut their price objective on shares of Doximity from $65.00 to $60.00 and set a "neutral" rating on the stock in a research report on Friday, May 16th. Zacks Research cut shares of Doximity from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Truist Financial lifted their price target on shares of Doximity from $52.00 to $61.00 and gave the company a "hold" rating in a research note on Thursday, July 17th. Finally, Raymond James Financial boosted their price target on shares of Doximity from $65.00 to $75.00 and gave the stock an "outperform" rating in a research report on Friday, August 8th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $66.21.

Doximity Stock Performance

NASDAQ:DOCS traded up $0.03 during mid-day trading on Tuesday, hitting $69.55. The stock had a trading volume of 769,564 shares, compared to its average volume of 2,240,005. Doximity, Inc. has a twelve month low of $36.12 and a twelve month high of $85.21. The stock has a market cap of $13.03 billion, a price-to-earnings ratio of 69.55, a PEG ratio of 4.10 and a beta of 1.37. The company's 50 day simple moving average is $62.83 and its 200 day simple moving average is $59.81.

Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same period last year, the business earned $0.28 EPS. The firm's quarterly revenue was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, equities analysts forecast that Doximity, Inc. will post 0.99 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Kira Scherer Wampler sold 2,000 shares of the firm's stock in a transaction that occurred on Friday, August 1st. The shares were sold at an average price of $57.09, for a total transaction of $114,180.00. Following the transaction, the director directly owned 16,618 shares of the company's stock, valued at approximately $948,721.62. This trade represents a 10.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Regina M. Benjamin sold 10,000 shares of Doximity stock in a transaction that occurred on Wednesday, June 25th. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the sale, the director owned 16,618 shares of the company's stock, valued at approximately $997,080. The trade was a 37.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 32,000 shares of company stock worth $1,929,380 in the last 90 days. Company insiders own 31.30% of the company's stock.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.